West Pharma (WST) Tops Q2 EPS by 34c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
Go back to West Pharma (WST) Tops Q2 EPS by 34c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 350.43 +1.01 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $349.42 | 52 Week High | $84.33 | |||
| Open | $348.00 | 52 Week Low | $53.88 | |||
| Day High | $350.67 | P/E | 223.20 | |||
| Day Low | $348.00 | EPS | $1.57 | |||
| Volume | 6,856 | |||||
